Results 51 to 60 of about 346 (122)

Kaposiform lymphangiomatosis with Kasabach–Merritt phenomenon

open access: yesPediatric Hematology/Oncology and Immunopathology
   Kaposiform lymphangiomatosis (KLA) is an aggressive lymphatic anomaly associated with bone involvement, serositis occurring at various sites, the development of Kasabach–Merritt phenomenon, and frequent infectious complications. The International Society for the Study of Vascular Anomalies classifies KLA as a subtype of generalized lymphatic anomaly.
L. A. Khachatryan   +5 more
openaire   +1 more source

Mosaicism of Vascular Origin

open access: yes
JEADV Clinical Practice, Volume 4, Issue 3, Page 697-699, August 2025.
Olivia Boccara
wiley   +1 more source

Additional file 1 of Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences

open access: yes, 2019
Table S1. Clinical Characteristics of patients with KLA or KHE. (DOCX 25 kb)
Ji, Yi   +4 more
openaire   +1 more source

Kaposiform lymphangiomatosis with spinal involvement [PDF]

open access: yesQJM: An International Journal of Medicine, 2019
S-Z, Liu   +4 more
openaire   +2 more sources

Pathogenic variants in PIK3CA are associated with clinical phenotypes of kaposiform lymphangiomatosis, generalized lymphatic anomaly, and central conducting lymphatic anomaly. [PDF]

open access: yesPediatr Blood Cancer, 2023
Grenier JM   +14 more
europepmc   +1 more source

Kaposiform lymphangiomatosis

open access: yes, 2020
Justin Rich, Arlene Campos, Yaïr Glick
openaire   +1 more source

Home - About - Disclaimer - Privacy